| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |